Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Awareness and Knowledge of the Surgical Safety Checklist Among Operational Staff in University Teaching Hospital, Kathmandu, Nepal: A Cross-sectional Questionnaire

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04126889
Recruitment Status : Completed
First Posted : October 15, 2019
Last Update Posted : October 15, 2019
Sponsor:
Information provided by (Responsible Party):
Yurie Kobashi, Fukushima Medical University

Brief Summary:

The introduction of the World Health Organization Surgical Safety Checklist (WHO SSC) is a priority to promote surgical safety. However, little is known regarding awareness and knowledge of the WHO SSC in developing countries. This study aimed to obtain region-specific information for the introduction of the checklist in a core medical institution in Nepal.

The present research was a cross-sectional study using data from a survey conducted at the Tribhuvan University Teaching Hospital (TUTH) in Kathmandu, Nepal. A questionnaire was distributed to 150 healthcare professionals working in the operating theatre. Responses to the questionnaire were analysed descriptively and regression analyses identified factors associated with awareness of the checklist.


Condition or disease Intervention/treatment
Surgical Checklist Other: questionnaire survey

Layout table for study information
Study Type : Observational [Patient Registry]
Actual Enrollment : 150 participants
Observational Model: Other
Time Perspective: Cross-Sectional
Target Follow-Up Duration: 2 Years
Official Title: Awareness and Knowledge of the Surgical Safety Checklist Among Operational Staff in University Teaching Hospital, Kathmandu, Nepal: A Cross-sectional Questionnaire
Actual Study Start Date : September 1, 2018
Actual Primary Completion Date : June 1, 2019
Actual Study Completion Date : October 1, 2019

Resource links provided by the National Library of Medicine



Intervention Details:
  • Other: questionnaire survey
    questionnaire survey


Primary Outcome Measures :
  1. Awareness of Surgical Safety Checklist [ Time Frame: 24 weeks ]
    Whether medical staffs know about Surgical Safety Checklist, Participants can answer to the question for yes or no.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   24 Years to 55 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
health professionals in operation room
Criteria

Inclusion Criteria:

  • have optimal experience

Exclusion Criteria:

  • less experience

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04126889


Locations
Layout table for location information
Nepal
Tribhuvan University Teaching Hospital
Kathmandu, Nepal
Sponsors and Collaborators
Fukushima Medical University

Layout table for additonal information
Responsible Party: Yurie Kobashi, Principal Investigator, Fukushima Medical University
ClinicalTrials.gov Identifier: NCT04126889    
Other Study ID Numbers: FukushimaMU
First Posted: October 15, 2019    Key Record Dates
Last Update Posted: October 15, 2019
Last Verified: October 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No